Completion surgery is a further operation after an earlier procedure and its findings. The tissue, reason and clinical setting determine the question; a pathology finding does not select one operation automatically.
In breast care, further surgery can mean re-excision of a cavity, completion mastectomy or completion axillary dissection. These remove different tissues and address different findings. The final margin or node assessment, earlier treatment and full clinical context matter. A further operation after initial pathology is not itself a recurrence or a treatment for disease throughout the body.
Z0011 studied a specified surgery-first population receiving lumpectomy and planned whole-breast radiation. AMAROS compared axillary dissection with radiation, rather than with no axillary treatment. Those studies do not directly answer residual positive sentinel nodes after neoadjuvant chemotherapy; A011202 studies that different setting. Finding more involved nodes by removing them is different from preventing recurrence, and harms such as lymphoedema need separate assessment.
Shares Breast cancer (all types) and the tags education-audit, local-treatment.
Shares Breast cancer (all types) and the tags education-audit, local-treatment.
Shares Breast cancer (all types) and the tags education-audit, local-treatment.
Shares Breast cancer (all types) and the tags education-audit, local-treatment.
Shares Breast cancer (all types) and the tags education-audit, local-treatment.
Shares the tags education-audit, local-treatment.
Shares AMAROS (EORTC 10981-22023), ACOSOG Z0011 (Alliance), Sentinel lymph node biopsy, Triple-negative breast cancer (TNBC).
Shares Triple-negative breast cancer (TNBC) and the tag education-audit.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/